C. Smith

In vivo nuclear delivery of oligonucleotides via hybridizing bifunctional peptides

L. Branden, B. Christensson, C. Smith, 2001, Gene Therapy.

Intercellular delivery of thymidine kinase prodrug activating enzyme by the herpes simplex virus protein, VP22

A. Phelan, A. Aints, M. Dilber, 1999, Gene Therapy.

A Peptide-based Vector for Efficient Gene Transfer In Vitro and In Vivo.

P. Lundin, I. Mäger, S. E. Andaloussi, 2011, Molecular therapy : the journal of the American Society of Gene Therapy.

Peptide Nanoparticle Delivery of Charge-Neutral Splice-Switching Morpholino Oligonucleotides

S. Hammond, M. Wood, M. Hällbrink, 2015, Nucleic acid therapeutics.

Extracellular vesicle in vivo biodistribution is determined by cell source, route of administration and targeting

Imre Mäger, Pieter Vader, Ylva Gustafsson, 2015, Journal of extracellular vesicles.

Proximal promoter of the murine syndecan‐1 gene is not sufficient for the developmental pattern of syndecan expression in B lineage cells

G. Gahrton, P. Jaakkola, M. Jalkanen, 2001, American journal of hematology.

Oligonucleotide Therapies: The Past and the Present

M. Behlke, K. E. Lundin, C. Smith, 2015, Human gene therapy.